Expression of telomerase genes in mamary atypical ductal hyperplasia.
- Author:
Min SONG
1
;
Xiaoyi MI
;
Bailin LI
;
Jijiang ZHU
;
Yingxian GAO
;
Shuang CUI
;
Jiye SONG
Author Information
- Publication Type:Journal Article
- MeSH: Breast Neoplasms; enzymology; pathology; Carcinoma, Intraductal, Noninfiltrating; enzymology; pathology; DNA-Binding Proteins; Female; Gene Expression; Humans; RNA, Messenger; Telomerase; genetics
- From: Chinese Journal of Pathology 2002;31(1):30-33
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the relationship of telomerase genes and the malignant transformation of atypical mammary ductal hyperplasia.
METHODSTelomerase genes hTR and hTRT in 50 cases of mammary hyperplasia (the cases included 6 benign hyperplasia, 9 mild atypical hyperplasia, 12 medium atypical hyperplasia, 23 severe atypical hyperplasia) and 26 cases of breast carcinoma were detected by in situ hybridization.
RESULTSThe expression of hTR and hTRT mRNA were weak or negative in benign hyperplasia (1/6, 0), weaker in mild-moderate atypical hyperplasia (2/9, 1/9, 4/12, and 3/12), strong in severe atypical hyperplasia (14/23, 60.9% and 12/23, 52.1%), while very strong expression (23/26, 88.5% and 21/25, 80.8%) in carcinoma of the breast. The difference between mild-moderate atypical hyperplasia, invasive ductal carcinoma and severe atypical hyperplasia was significant (P < 0.05) and the difference between severe atypital hyperplasia and intraductal carcinoma was not significant (P > 0.05).
CONCLUSIONSTelmerase genes (hTR, hTRT) expression is closely related to the malignant transformation of atypical hyperplasia. The reactivated telomerase may play a crucial role in the development of breast cancer.
